MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Changes in motor subtype designation of early Parkinson’s disease patients

R. Eisinger, D. Martinez-Ramirez, C. Hess, M. Okun, A. Gunduz (Gainesville, FL, USA)

Meeting: 2017 International Congress

Abstract Number: 1098

Keywords: Parkinsonism

Session Information

Date: Wednesday, June 7, 2017

Session Title: Phenomenology and Clinical Assessment Of Movement Disorders

Session Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Objective: To examine changes in the designation of motor subtypes in Parkinson’s disease (PD) patients within five years of diagnosis.

Background: Distinct motor subtypes of PD have been identified through both clinical observation and data-driven approaches. However, the extent to which motor subtypes are mutable during disease progression is not fully known.

Methods: We used the Parkinson’s Progression Markers Initiative database of 423 newly diagnosed PD patients to identify unique motor subtypes. Specifically, we found distinct 1) Tremor Dominant (TD), 2) Axial-dominant (AxD), 3) Appendicular-dominant (ApD), 4) Rigidity-dominant (RD), and 5) Postural Instability and Gait Disorder (PIGD) groups. We converted these categories to an ordinal scale by assigning the subtypes numerical values 1 through 5, as they progressed on the spectrum between TD to PIGD respectively. Next, for each off-medication motor assessment time point, we assigned patients to one of these five subtypes. Patients with consistent subtypes and patients with inconsistent subtypes were analyzed separately. For patients with inconsistent subtypes, we computed relative subtype frequencies over time using a bin width of 6 months to produce sample-level averages.

Results: The number of motor assessment time points for each patient ranged from 2 to 14 (M= 6.81, SD = 2.40). Subtypes for 54.8% of patients were consistent at every time point while 45.2% of patients fit criteria for at least two different subtypes across time points. A chi-square test suggests that subtype frequencies change over time, X2(25) = 42.01, p < 0.05. Using the numerical scale described above, a linear regression showed that average subtype increased with disease duration, R2 = 0.61, p < 0.05 [figure1]. In other words, on the spectrum from TD to PIGD, the cohort as a whole progressed away from a TD phenotype with disease progression. These results suggest that at least in early PD, motor subtypes may change or progress over time.

Conclusions: Early PD subtypes are stable for some patients and unstable for others. By frequency, more patients are classified as TD soon after diagnosis. There is an overall shift away from TD within the first five years of diagnosis. These results suggest that motor subtype designation may be influenced by disease duration.

To cite this abstract in AMA style:

R. Eisinger, D. Martinez-Ramirez, C. Hess, M. Okun, A. Gunduz. Changes in motor subtype designation of early Parkinson’s disease patients [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/changes-in-motor-subtype-designation-of-early-parkinsons-disease-patients/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/changes-in-motor-subtype-designation-of-early-parkinsons-disease-patients/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley